✉news BusinessStartups first seen 12 h ago, last 6 min ago, peak #3
Shionogi to buy rare disease startup for $2 billion
Original: Shionogi pays $2B to acquire a rare disease startup
Japanese drugmaker Shionogi has agreed to acquire a rare disease startup in a deal worth around $2 billion, according to BioPharma Dive. The move signals Shionogi's push to expand beyond its core infectious disease franchise into rare disease treatments, a growing area of interest for large pharmaceutical companies seeking new growth drivers and specialized pipelines.
Why now: Pharma dealmaking in rare disease remains a hot topic as large drugmakers buy up innovative biotech pipelines.
Rank over time, top of the chart is #1. 10 snapshots from 12 h ago to 6 min ago.
Evidence
- Shionogi pays $2B to acquire a rare disease startup · BioPharma Dive
API: https://socialmediatrends-api.osmike.com/v1/trends/1135857